Pharmacodynamics of 5-fluorouracil and leucovorin.
Gustavsson
B G
BG
Ostra sjukhuset, University of Gothenburg, Sweden.
Carlsson
G
G
Frösing
R
R
Spears
C P
CP
D000230:Adenocarcinoma / Q000188:drug therapy; D000818:Animals; D001853:Bone Marrow / Q000378:metabolism*; D003110:Colonic Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D003856:Deoxyuracil Nucleotides / Q000378:metabolism; D005468:Fluorodeoxyuridylate / Q000378:metabolism; D005472:Fluorouracil / Q000493:pharmacokinetics* / Q000627:therapeutic use; D006801:Humans; D007413:Intestinal Mucosa / Q000378:metabolism; D002955:Leucovorin / Q000494:pharmacology* / Q000627:therapeutic use; D008099:Liver / Q000378:metabolism*; D010190:Pancreatic Neoplasms / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D012004:Rectal Neoplasms / Q000378:metabolism*; D013274:Stomach Neoplasms / Q000378:metabolism*; D013940:Thymidylate Synthase / Q000378:metabolism*
D003856:Deoxyuracil Nucleotides; D005468:Fluorodeoxyuridylate; C007267:2'-deoxyuridylic acid; D013940:Thymidylate Synthase; D002955:Leucovorin; D005472:Fluorouracil